BridgeBio Pharma

BBIO

0 Followers
$34.17 -1.95% -$0.68
Follow
7 August
Upcoming Earnings
 
Market Cap.
 
P/E
Overview Metrics Financials
Loading...

BBIO Fair Price

$05.36
Undervalued by 33.7%
To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

BridgeBio Pharma, Inc. is an American biotechnology company focused on the development and commercialization of innovative drugs for rare genetic diseases and cancer. Founded in 2015, the company's primary goal is to develop medicines that target the underlying genetic mechanisms causing various rare diseases. BridgeBio leverages advanced scientific technologies to identify genetic causes of diseases and then develops therapeutic options that may alleviate or even eliminate the symptoms of these conditions. The company has a portfolio of therapeutic programs in various stages of clinical trials and collaborates with other biotechnology companies and research institutions to accelerate the development of its products.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade